Journal of Infectious Diseases and Medicine

ISSN: 2576-1420

Open Access

Abdelrafie M. Makhawi

Department of Biotechnology, College of Applied and Industrial Sciences, University of Bahri, Khartoum, Sudan

  • Perspective   
    Antibody Fragment VH ab6: Universal Neutralizer for SARSCoV- 2 Variants
    Author(s): Mujahed I. Mustafa* and Abdelrafie M. Makhawi

    The recent COVID-19 outbreak demonstrated how ineffectively may face newly emerging viruses. Antiviral drugs are the most effective way to combat the COVID-19 pandemic. However, their rapidly declining immunity and a large population of unvaccinated people will provide a recombinant ground for the virus's spread and the era of novel variants, posing a continuous threat of infection for vulnerable groups with inadequate immune responses. In order to treat infected people, effective treatments must be developed. In this short note, discuss a breakthrough in engineered antibody fragment that could be neutralized the shield against the battle of the continuous waves of SARS-CoV-2 variants as well as future other viral infections... Read More»
    DOI: 10.37421/2576-1420.2023.8.274

    Abstract HTML PDF

Google Scholar citation report
Citations: 59

Journal of Infectious Diseases and Medicine received 59 citations as per Google Scholar report

Journal of Infectious Diseases and Medicine peer review process verified at publons

Indexed In

arrow_upward arrow_upward